Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Here's Sorrento's history(from the website)
Founded
2013

Acquired Resiniferatoxin (RTX) assets via the acquisition of Sherrington Pharmaceuticals Inc.
Acquired Antibody Drug Conjugation (ADC) technologies via acquisition of Concortis Biosystems Corp.
2014

Out-licensed PD-L1 for Greater China market to Lee’s Pharm
2016

Formed ImmuneOncia JV with Yuhan Pharmaceuticals
Acquired ZTlido® via majority stake in Scilex Pharmaceuticals
Acquired Bioserv Corporation for cGMP manufacturing operations
Formed Levena Suzhou Biopharma Co. LTD for Antibody Drug Conjugation (ADC) services
2017

Acquired Oncolytic Virus platform via the acquisition of Virttu Biologics Limited
Formed Celularity with Celgene and United Therapeutics
2018

Acquired Sofusa® Lymphatic Delivery System from Kimberly-Clark
2019

Acquired Semnur Pharmaceuticals
Formed Scilex Holding to consolidate the merger of Scilex Pharma and Semnur Pharma
2020

Exclusively licensed Abivertinib from ACEA Therapeutics for all indications worldwide, excluding China
Exclusively licensed HP-LAMP diagnostic platform from Columbia University for the detection of coronaviruses and influenza viruses
Acquired SmartPharm Therapeutics
2021

Acquired ACEA Therapeutics

MY ONLY COMMENT IS THIS. THEY'VE MADE A LOT OF EXCELLENT ACQUISITIONS!